Evidence map›Paper›PMID 40249736›Full record

ArticlePloS one2025

Exposure to air pollutants contributes to increased rate of neovascular age-related macular degeneration in Israel.

Alon Sela, Rinat Levinshtein, Shiri Shulman

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alon SelaAgricultural and Biosystems Engineering, Agriculture Research Organization (ARO), Rishon LeZion, Israel.ORCID 0000-0001-5544-0837
Rinat LevinshteinDepartment of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
Shiri ShulmanAssuta Medical Centre, Tel-Aviv, Israel.ORCID 0000-0002-3188-3470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a multi-factorial degenerative disease of the retina and the leading cause for vision loss in the developed world. Air pollution is considered the greatest environmental threat to public health globally. Accumulating evidence indicates that air pollution may be a modifiable risk factor for chronic eye diseases of the lens and retina, including AMD. We examined the concentration of seven air pollution particles and their influence on the prevalence of neovascular AMD in Israel. Records of patients with AMD between 2016 and 2019 were crossed with their residential areas and correlated with pollution data. AMD rates were correlated with 5 types of gas: nitrogen dioxide (NO2), nitrogen oxide (NO), carbon monoxide (CO), ozone (O3), sulphur dioxide (SO2), and particulate matter - PM2.5 and PM10. A total of 93 localities across Israel were included in the analysis. AMD rates were higher in localities with greater air pollution. NO2, NOx, and PM2.5 were positively correlated with AMD rates, while O3 was negatively correlated with AMD rates. However, analysis of the effect of all air pollutant particles combined, showed a complex and highly non-linear effect on AMD rate, with the strongest non-linearity observed for carbon monoxide. NO2, NOx, and PM2.5 contribute to higher rate of AMD in Israel while O3 seems to have a protective role (probably due to ultraviolet filtering) on AMD rates. The interaction between air pollutants and AMD seems to be complex and non-linear and should be further studied.

Indexed as

Air PollutantsAir PollutionEnvironmental ExposureMacular DegenerationAgedAged, 80 and overCarbon MonoxideFemaleHumansIsraelMaleMiddle AgedNitrogen DioxideOzoneParticulate MatterPrevalenceAir PollutantsCarbon MonoxideNitrogen DioxideOzoneParticulate Matter

Identifiers

PMID40249736
PMCPMC12007707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.